Ophthalmology Times - Ophthalmology news, articles, and events
网页Retina Society 2024: Observational, retrospective US-based cohort study on newly diagnosed geographic atrophy. This Week in Ophthalmology: Week of September 1, 2024. VLOG: NeuroOp Guru: Multiple Sclerosis associated with reduced choroidal vascularity indicating uveal component to MS. This Week in Ophthalmology: Week of August 25, 2024.
Physicians sort out pros and cons of several new IOLs on the market
网页2021年11月12日 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
FDA approves IPL device to manage dry eye disease
网页April 29, 2021. By David Hutton. Article. After receiving FDA approval for its IPL device, Lumenis Ltd. announced that it is launching OptiLight, a bright solution for dry eyes. The FDA has granted De Novo authorization to Lumenis Ltd. for its newest IPL device for improving signs of dry eye disease due to meibomian gland dysfunction (MGD).
Intracameral medication use requires careful consideration of …
网页2008年2月1日 · Advantages of using intracameral medications in cataract surgery for anesthesia, pupil dilation, or to prevent inflammation and endophthalmitis include ease of delivery, elimination of toxicity of topical drops, and avoidance of compliance issues, he said. In addition, by delivering the treatment directly to the target site, intracameral ...
Treating vitreous opacities with YAG laser vitreolysis
网页2021年1月18日 · This article was reviewed by Netan Choudhry, MD, FRCSC YAG laser vitreolysis is a less-invasive option than pars plana vitrectomy for patients who are affected by vitreous opacities (floaters), according to Netan Choudhry, MD, FRCSC, of Vitreous Retina Macula Specialists of Toronto. Although floaters are typically clinically …
Breaking down the dorzolamide shortage - Ophthalmology Times
网页2019年8月9日 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a …
Differential diagnosis key to treatment of pale optic nerve
网页2004年10月15日 · Buffalo, NY-In the absence of optic nerve swelling, the clinician may be faced with a difficult diagnosis in a patient with a pale optic nerve, according to Norah S. Lincoff-Cohen, MD.A comprehensive differential diagnosis needs to be made to rule out disorders that may require immediate treatment. "The first thing I worry about is the …
EDTA chelation provides solution for band keratopathy
网页2005年10月15日 · Baltimore—Ethylene diamine tetra-acetic acid (EDTA) chelation offers a low-tech, low-cost, effective treatment for calcific band keratopathy associated with chronic uveitis and other disorders, said James P. Dunn, MD, at the Current Concepts in Ophthalmology meeting, sponsored by Johns Hopkins University School of Medicine and …
Alcon reveals final data from Vivity Registry Study which …
网页2023年9月13日 · Alcon has announced final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).
Topical moxifloxacin: Best choice before cataract surgery?
网页2020年7月29日 · The use of topical moxifloxacin instilled onto the ocular surface before cataract surgery may not be effective for reducing the corneal surface flora in most patients, according to Caroline W. Wilson, MD, an ophthalmology resident, Department of Ophthalmology and Visual Sciences at University of Iowa Hospitals and Clinics in Iowa City.
跳至内容